FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| OLYMPIA PHARMACY | 017674368 | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Hydroxocobalamin; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride | 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg | 2019-2 | source_no_ndc | 2026-11-14 | |||
| OLYMPIA PHARMACY | 017674368 | Levocarnitine; Pyridoxine Hydrochloride; Succinylcholine Chloride; Methionine; Hydroxocobalamin; Inositol; Riboflavin 5'-Phosphate Sodium; Thiamine Hydrochloride | 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg; 5 mg/5 mg | 2019-2 | source_no_ndc | 2026-11-14 | |||
| OLYMPIA PHARMACY | 017674368 | Lidocaine | 10 mg/500 mg | 2019-2 | source_no_ndc | 2026-11-14 | |||
| OLYMPIA PHARMACY | 017674368 | Lidocaine | 20 mg/500 mg | 2019-2 | source_no_ndc | 2026-11-14 | |||
| OLYMPIA PHARMACY | 017674368 | Lidocaine Hydrochloride; Glutamine; Ornithine; Lysine Hydrochloride; Arginine; Citrulline | 10 mg/250 mg; 30 mg/250 mg; 50 mg/250 mg; 50 mg/250 mg; 100 mg/250 mg; 50 mg/250 mg | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Moxifloxacin Hydrochloride | 1.5 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Moxifloxacin Hydrochloride | 1 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Potassium Palmitate | 620 ug/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Povidone-Iodine | 5 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Povidone-Iodine | 5 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Remifentanil Hydrochloride | 50 ug/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Sodium Glycolate | 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Sodium Oxalate | 1.36 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bevacizumab | 25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Brilliant Blue G | .25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Tropicamide; Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride | 10 mg/1 mL; 25 mg/1 mL; 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Vancomycin Hydrochloride | 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 3.75 mg/1 mL; 20 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Vancomycin Hydrochloride; Gentamicin Sulfate | 1 mg/.12 mL; 4 mg/.12 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Chloride | 20 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Gluconate | 25 mg/1 g | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Gluconate | 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Calcium Gluconate | 25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Ceftazidime | 22.5 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Cefuroxime Sodium | 10 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Dexamethasone Sodium Phosphate | 24 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Dextrose | 77.9 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Epinephrine Hydrochloride; Lidocaine Hydrochloride | .25 mg/1 mL; 7.5 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Glycerin | 11.7 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Aflibercept | 25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine | 300 mg/1 g | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine Hydrochloride | 40 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 20 mg/1 mL; .25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine Hydrochloride; Oxymetazoline Hydrochloride | 20 mg/1 mL; .25 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 10 mg/1 mL; 15 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| Pine Pharmaceuticals LLC | 079432784 | Lidocaine; Tetracaine; Benzocaine | 60 mg/1 g; 40 mg/1 g; 200 mg/1 g | 2019-2 | source_no_ndc | 2026-11-14 | |||
| PROVIDENCE INFUSION HOSPITAL SERVICES | 079990088 | Oxytocin | .06 U/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| PROVIDENCE INFUSION HOSPITAL SERVICES | 079990088 | Vancomycin | 1.25 g/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| PROVIDENCE INFUSION HOSPITAL SERVICES | 079990088 | Vancomycin | 1.5 g/250 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| PROVIDENCE INFUSION HOSPITAL SERVICES | 079990088 | Cefazolin | 100 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| PROVIDENCE INFUSION HOSPITAL SERVICES | 079990088 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 | |||
| PROVIDENCE INFUSION HOSPITAL SERVICES | 079990088 | Lidocaine | 9 mg/1 mL | 2019-2 | source_no_ndc | 2026-11-14 |